ASCEND BY NTHRYS
Research Abroad Products

Immunotechnology Project Topics

Browse all focused areas across all project categories under this field.

Showing 133–144 of 200 project topics
Immunotechnology Licensing Deal Intelligence Platform
A commercial intelligence tool that tracks global immunotherapy licensing agreements, royalty benchmarks, and partnership trends across 50+ database sources. Enables deal makers to negotiate optimal licensing terms and identify emerging monetization opportunities.
Immunotechnology IP & Licensing Strategy Tools Click to view more details →
Monoclonal Antibody IP Valuation and Pricing Engine
An advanced analytics platform that calculates fair market value for monoclonal antibody patents using comparable licensing data and regulatory milestones. Streamlines licensing negotiations and enables accurate financial modeling for M&A transactions.
Immunotechnology IP & Licensing Strategy Tools Click to view more details →
CAR-T Cell Technology Patent Clearance and FTO Software
A specialized FTO analysis tool designed specifically for CAR-T and cell therapy immunotechnologies, identifying blocking patents and licensing requirements before clinical development. Protects companies from costly patent litigation and accelerates product commercialization timelines.
Immunotechnology IP & Licensing Strategy Tools Click to view more details →
Checkpoint Inhibitor Patent Estate Management Suite
A comprehensive IP management platform for PD-1, PD-L1, and CTLA-4 patent portfolios, tracking prosecution, maintenance, and renewal across jurisdictions. Maximizes patent lifecycle value and enables strategic licensing of immunotherapy checkpoint modalities.
Immunotechnology IP & Licensing Strategy Tools Click to view more details →
Vaccine Technology IP Rights Holder Database and Licensing Marketplace
A B2B marketplace platform connecting vaccine immunotechnology patent holders with licensees, featuring standardized licensing templates and automated contract management. Creates new revenue streams through direct peer-to-peer IP transactions and reduces intermediary costs.
Immunotechnology IP & Licensing Strategy Tools Click to view more details →
Immunotoxicology Patent Risk Assessment and Compliance Tool
A regulatory and patent risk assessment platform for immunotoxicology-related immunotherapy assets, tracking liability patents and toxicity-related IP claims. Helps companies manage risk portfolios and structure licensing deals with embedded indemnification protections.
Immunotechnology IP & Licensing Strategy Tools Click to view more details →
Therapeutic Patent Class Clustering and Commercial Opportunity Analyzer
An AI-powered analytics tool that clusters immunotherapy patents by therapeutic potential and commercial viability, identifying white-space opportunities and licensing targets. Accelerates strategic deal sourcing and enables data-driven investment decisions.
Immunotechnology IP & Licensing Strategy Tools Click to view more details →
Multi-Jurisdictional Immunotech IP Prosecution and Renewal Management Service
A managed services platform that handles global patent prosecution, maintenance, and renewal workflows for immunotechnology portfolios across 100+ countries. Reduces administrative overhead by 60% and ensures maximized patent protection for licensing value.
Immunotechnology IP & Licensing Strategy Tools Click to view more details →
Real-time Immunotherapy Clinical Trial Matching SaaS
A cloud-based platform that matches patients to immunotherapy clinical trials using AI-driven genomic and immunological profiling data. It generates revenue through subscription licensing to pharmaceutical companies, CROs, and academic medical centers conducting immunotherapy research.
Immunotechnology Market Intelligence Analytics Click to view more details →
CAR-T Cell Manufacturing Process Optimization Software Suite
An integrated software solution that monitors and optimizes CAR-T cell manufacturing workflows, quality parameters, and yield metrics in real-time. It reduces manufacturing costs and time-to-market, creating revenue through licensing fees and performance-based pricing models for cell therapy manufacturers.
Immunotechnology Market Intelligence Analytics Click to view more details →
Multiparametric Flow Cytometry Data Analytics Platform
An enterprise analytics tool that processes, visualizes, and interprets complex flow cytometry datasets with machine learning-enhanced gating and population identification. It accelerates research cycles and validates immunological biomarkers, generating revenue through per-assay licensing and institutional subscriptions.
Immunotechnology Market Intelligence Analytics Click to view more details →
Checkpoint Inhibitor Response Prediction Commercial Tool
A predictive analytics platform that forecasts patient responses to PD-1/PD-L1 and CTLA-4 checkpoint inhibitors using integrated genomic, transcriptomic, and imaging biomarkers. It enables precision dosing and patient stratification strategies, creating revenue through licensing to oncology pharma companies and healthcare systems.
Immunotechnology Market Intelligence Analytics Click to view more details →